Milestone Achievement for THINK Surgical's TMINI System
THINK Surgical, Inc., an innovator in orthopedic surgical robotics, proudly announces an impressive milestone with its TMINI Miniature Robotic System being utilized in over 500 successful total knee arthroplasty (TKA) procedures. This achievement underscores the growing adoption and enthusiasm among medical professionals for this groundbreaking technology.
Surgeon Feedback and System Efficiency
Stuart Simpson, the President and Chief Executive Officer of THINK Surgical, expressed his excitement about reaching this significant achievement so quickly. He remarked, “Achieving this 500-case milestone so quickly demonstrates the market's eagerness to adopt our miniature, handheld, wireless robot. Surgeon and hospital staff using the TMINI System report high satisfaction due to its accuracy and efficiency in the operating room,”.
Customer Pipeline and Future Prospects
Simpson further emphasized the company's optimism regarding their customer pipeline, indicating that they anticipate seeing many more successful TKA procedures completed with the TMINI Robot. This forward momentum reflects THINK Surgical's commitment to provide innovative solutions in orthopedic surgery.
Unmatched Features of the TMINI System
The TMINI Miniature Robotic System stands out in the market, equipped with nine FDA 510(k) cleared implant partners. It allows surgeons and hospital administrators to choose from a variety of implants. This flexibility enhances the decision-making process in surgical settings. Notably, the TMINI System boasts the highest variety of implant designs and philosophies available from any robotic system currently on the market, being the only miniature, handheld, wireless robot in the U.S.
FDA Clearances and Updates
Initially cleared by the FDA in May 2023 with a single implant partner, the TMINI Miniature Robotic System has significantly advanced. It has received multiple clearances for the TMINI 1.1 Version Update, which integrates the TMINI PRO™ Workflow, allowing for precise positional refinement and optimization of the implant. Additionally, eight more implant partners have been cleared, further reinforcing this system’s versatility and appeal to surgeons.
Available Options for Surgeons
This cutting-edge robotic system is currently commercially available throughout the United States, offering unparalleled options for orthopedic procedures.
About THINK Surgical, Inc.
THINK Surgical, Inc. is a privately held technology innovator based in the U.S. that designs and markets advanced orthopedic robots. Their robotic systems are recognized for being open platforms, supporting implants from various manufacturers, thus giving the implants' choice authority back to surgeons.
With a commitment to enhancing patient outcomes, THINK Surgical engages with healthcare professionals worldwide. They continuously refine their orthopedic products, aiming to improve the quality of life for individuals suffering from advanced joint diseases through precise and intelligent surgical technology.
Contact Information
For further information about THINK Surgical's products, please reach out to their media contact.
Media Contact:
THINK Surgical Inc.
Nick Margree
[email protected]
Frequently Asked Questions
What is the TMINI Miniature Robotic System?
The TMINI Miniature Robotic System is an innovative handheld, wireless robotic technology used for orthopedic surgeries, particularly total knee arthroplasty.
How many procedures have used the TMINI System?
As of now, the TMINI Miniature Robotic System has been used in over 500 total knee arthroplasty procedures.
What are the unique features of the TMINI System?
The TMINI System offers unique features, including compatibility with nine FDA-cleared implant partners and the ability for surgeons to choose from various implants.
When was the TMINI System cleared by the FDA?
The TMINI Miniature Robotic System initially received FDA clearance in May 2023.
Where is the TMINI System available?
The TMINI Miniature Robotic System is commercially available throughout the United States, making it accessible to a wide range of surgeons and hospitals.
